Q3 2025 Earnings Call Transcript November 4, 2025 Heron Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

Get the latest analysis on Heron Therapeutics (HRTX): current challenges, future outlook, and key growth factors. Click here ...

Heron Therapeutics Inc ((HRTX)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock ...

Heron Therapeutics, Inc. (Nasdaq: HRTX) ('Heron” or the 'Company”), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Tuesday, ...

Heron Therapeutics Inc (HRTX) reports robust sales growth and strategic initiatives, despite facing challenges in gross margins and competitive market dynamics.

Generated Q3 2025 Net Revenue of $38.2 million and year-to-date revenue of $114.3 million; reaffirmed 2025 Net Revenue Guidance of $153 million - ...